SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, ...

RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the ...

Swara Bhasker's old interview is trending again. Loni Anderson's Cause Of Death Revealed ‘Burger King mom’, who went viral for running busy restaurant solo, has been fired Cracker Barrel loses almost ...

SAN FRANCISCO, Aug. 22, 2025 /PRNewswire/ -- Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision therapies for neurodegenerative diseases, today announced it ...

ST. LOUIS – A St. Louis mother has filed a lawsuit against Roblox, claiming her 13-year-old daughter was groomed and sexually exploited by a man she met while playing the online game. According to our ...

SUHAR: Nama Water Services is implementing a vital project for the rehabilitation and maintenance of water distribution networks in Al Batinah North Governorate. The project, costing over RO 2 million ...

A £3bn deal has been signed to overhaul a 70-year-old aqueduct that supplies water to more than 2.5m customers across north-west England. The agreement between United Utilities and water projects ...

Key Laboratory of Emergency and Trauma of Ministry of Education, Department of Joint Surgery, The First Affiliated Hospital, Hainan Medical University, Haikou 570102, P. R. China ...

Arthur Hayes returns to active crypto investing, focusing on DeSci projects, political meme coins, and DAT firms. Today, he invested $1 million in BIO, triggering significant market movements and a 20 ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on July 8, Upstream Bio announced that the first patient had been dosed in a Phase 2 ...

Adaptive Biotechnologies lost a powerhouse partner after Roche subsidiary Genentech walked away from a potentially $2 billion cancer-focused cell therapy collaboration. The Washington-based biotech ...